Histone deacetylases: salesmen and customers in the post‐translational modification market
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
HDACs (histone deacetylases) are enzymes that remove the acetyl moiety from N‐∍‐acetylated lysine residues in histones and non‐histone proteins. In recent years, it has turned out that HDACs themselves are also subject to post‐translational modification. Such structural alterations can determine the stability, localization, activity and protein—protein interactions of HDACs. This subsequently affects the modification of their substrates and the co‐ordination of cellular signalling networks. Intriguingly, physiologically relevant non‐histone proteins are increasingly found to be deacetylated by HDACs, and aberrant deacetylase activity contributes to several severe human diseases. Targeting the catalytic activity of these enzymes and their post‐translational modifications are therefore attractive targets for therapeutical intervention strategies. To achieve this ambitious goal, details on the molecular mechanisms regulating post‐translational modifications of HDACs are required. This review summarizes aspects of the current knowledge on the biological role and enzymology of the phosphorylation, acetylation, ubiquitylation and sumoylation of HDACs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · cited 1×
“The proper regulation of HDACs appears critical for the maintenance of homoeostasis, which is exemplified by deregulated HDAC activity in certain severe human malignancies (Bolden et al., 2006; Glozak and Seto, 2007).”
BackgroundMétivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Histone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031 · cited 3×
“Conclusions Analysing the biochemistry and interplay of posttranslational modifications of HDACs can elucidate their biological functions and determine whether aberrant HDAC modifications are associated with disease (Glozak and Seto, 2007).”
BackgroundRosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium
Pugacheva, E. N., Jablonski, S. A., Hartman, T. R., Henske, E. P., & Golemis, E. A. (2007) · Cell · doi:10.1016/j.cell.2007.04.035 · Cited by 890 · cited 1×
“Recently, it was shown that the oncogenic Aurora A kinase induces phosphorylation and activation of HDAC6 (Pugacheva et al., 2007).”
BackgroundBali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500186200 · Cited by 755 · cited 1×
“In light of this, the contribution of HDAC6 to the clearance of misfolded protein aggregates heavily conjugated to ubiquitin may explain the strong cytotoxic effects seen when HDAC6 is inhibited (Kawaguchi et al., 2003; Bali et al., 2005; Boyault et al., 2007).”
BackgroundClass II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664 · cited 2×
“…Heinzel and O.H. Krämer a tissue-specific manner, and are modulated by several signal transduction pathways (Khochbin et al., 2001; Krämer et al., 2001; Grozinger and Schreiber, 2002; de Ruijter et al., 2003; Verdin et al., 2003; Hildmann et al., 2007; Martin et al., 2007; Yang and Seto, 2008).”
BackgroundGhisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.-E., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.022 · Cited by 561 · cited 2×
“The proper regulation of HDACs appears critical for the maintenance of homoeostasis, which is exemplified by deregulated HDAC activity in certain severe human malignancies (Bolden et al., 2006; Glozak and Seto, 2007).”
BackgroundMice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.-L., Chua, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-06 · Cited by 559
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523 · cited 2×
“We revealed direct conjugation of ubiquitin to HDAC2 in vitro and in vivo (Krämer et al., 2003).”
BackgroundFunctional significance of histone deacetylase diversity
Khochbin, S., Verdel, A., Lemercier, C., & Seigneurin-Berny, D. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00174-x · Cited by 366 · cited 2×
“…(4) | Pages 193–205 193 A. Brandl, T. Heinzel and O.H. Krämer a tissue-specific manner, and are modulated by several signal transduction pathways (Khochbin et al., 2001; Krämer et al., 2001; Grozinger and Schreiber, 2002; de Ruijter et al., 2003; Verdin et al., 2003; Hildmann et al., 2007;…”
BackgroundSeigneurin-Berny, D., Verdel, A., Curtet, S., Lemercier, C., Garin, J., Rousseaux, S., & Khochbin, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8035-8044.2001 · Cited by 335 · cited 1×
“Regarding class II HDACs, HDAC6 interacts with ubiquitin and proteins of the ubiquitin signalling pathway (Seigneurin-Berny et al., 2001).”
BackgroundRegulation of MEF2 by Histone Deacetylase 4- and SIRT1 Deacetylase-Mediated Lysine Modifications
Zhao, X., Sternsdorf, T., Bolger, T. A., Evans, R. M., & Yao, T.-P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8456-8464.2005 · Cited by 264 · cited 3×
“Since HDAC5 was not found to be ligated to SUMO1 in vivo, it is unlikely that sumoylation of class II members is involved in the regulation of their sumoylationpromoting functions (Gregoire and Yang, 2005; Zhao et al., 2005).”
BackgroundResultSUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities
David, G., Neptune, M. A., & DePinho, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203690200 · Cited by 236 · cited 4×
“In 2002, two groups described SUMO1 modification of HDAC1 and showed that Lys444 and Lys476 are the main acceptor sites in vitro as well as in vivo (Colombo et al., 2002; David et al., 2002).”
BackgroundInfluentialRegulation of histone deacetylase 2 by protein kinase CK2
Tsai, S.-C., & Seto, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204149200 · Cited by 196 · cited 4×
“Nevertheless, HDAC2S394,411,422,424A and even HDAC2 380− 488 repressed a Gal4-driven luciferase reporter as wild-type HDAC2 (Tsai and Seto, 2002).”
BackgroundInfluentialNegative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A
Lee, H., Rezai-Zadeh, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.765-773.2004 · Cited by 153 · cited 1×
“In addition, the Seto laboratory demonstrated that PKA mediates phosphorylation of HDAC8, with Ser39 being the primary phosphoacceptor site (Lee et al., 2004).”
BackgroundPP2A Regulates HDAC4 Nuclear Import
Paroni, G., Cernotta, N., Dello Russo, C., Gallinari, P., Pallaoro, M., Foti, C., Talamo, F., Orsatti, L., Steinkühler, C., & Brancolini, C. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0623 · Cited by 126 · cited 2×
“Ser298 also contributes to the nuclear import of HDAC4.”
BackgroundJohnson, C. A., White, D. A., Lavender, J. S., O'Neill, L. P., & Turner, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107942200 · Cited by 119 · cited 1×
“Unlike acetylated peptides, deacetylation of purified mononucleosomes by HDAC1 might require its association with the heatshock proteins Hsp60/Hsp70, but not with Hsp90 (Johnson et al., 2002).”
Background
Cited by
The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis
Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.011 · Cited by 891
Delcuve, G. P., Khan, D. H., & Davie, J. R. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-5 · Cited by 505
Epigenetic mechanisms of regulation of Foxp3 expression
Lal, G., & Bromberg, J. S. (2009) · Blood · doi:10.1182/blood-2009-05-219584 · Cited by 373
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Epigenome manipulation as a pathway to new natural product scaffolds and their congeners
Cichewicz, R. H. (2010) · Nat. Prod. Rep. · doi:10.1039/b920860g · Cited by 282
Metadata
- Authors
- Brandl, A., Heinzel, T., & Krämer, O. H.
- Venue
- Biology of the Cell
- Publisher
- Wiley
- Published
- 2009-04
- Volume
- 101
- Issue
- 4
- Pages
- 193-205
- ISSN
- 0248-4900 (ISSN-L)
- 1768-322X
- OpenAlex
- W2145520741
- Cited by
- 107
- References
- 19
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.